[68Ga]Ga-DOTA-TATE is a selective radiopharmaceutical binding to somatostatin receptors subtype-2 (SSTR-2) that has been developed in the field of oncology, especially in neuroendocrine tumors with higher performance compared to other radiopharmaceuticals [111]. This evidence concerns the gene SSTR2 and neuroendocrine neoplasm.